Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
6/1/1992
1.
Phase I/II Study of Lometrexol in Patients with Ovarian Adenocarcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Supportive care, Treatment
Completed
18 and over
MSKCC-91173
NCI-V92-0026
Last Modified:
11/1/2002
 
First Published:
4/1/2002
2.
Phase II Study of Lometrexol and Folic Acid in Patients With Previously Treated Stage IIIB or IV Non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
TULA-T064031
USO-01103, NCT00033722
Last Modified:
8/1/1997
3.
Phase I Study of Lometrexol/Folic Acid for Solid Tumors and Lymphomas (Summary Last Modified 08/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
MCV-MCC-9408-2B
NCI-T94-0121O, T94-0121
Last Modified:
2/1/1996
4.
Phase I Study of Lometrexol/Folic Acid for Advanced Solid Tumors (Summary Last Modified 02/96)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
21 and over
NCI
LAC-USC-0C941
NCI-T94-0142H, T94-0142
Last Modified:
12/4/2002
 
First Published:
9/1/2001
5.
Phase I Study of Lometrexol, Paclitaxel, and Folic Acid in Patients With Locally Advanced or Metastatic Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Supportive care, Treatment
Closed
18 and over
NCI, Pharmaceutical / Industry
UCLA-0005068
TULA-T3004, NCI-G01-2017, NCT00024310
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute